PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk

Researchers have developed a method to predict early on which patients with breast cancer are most likely to stop taking potentially life-saving aromatase inhibitor drugs

Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk
2023-12-06
(Press-News.org)

A new risk model uses baseline sociodemographic and financial measures to predict which patients prescribed long-term therapy with aromatase inhibitors for breast cancer are at significantly higher risk of stopping that therapy early (non-adherence).

The work will be presented in a poster spotlight discussion session at the 2023 San Antonio Breast Cancer Symposium (SABCS) on Wednesday, December 6th.

The authors analyzed data from the SWOG S1105 clinical trial, including measures of patient adherence to aromatase inhibitor (AI) therapy for hormone-sensitive breast cancer. They created a model composed of individual sociodemographic and financial factors – as well as measures of area-level deprivation and rural/urban location – that were statistically significantly associated with  adherence. The presence of each additional risk factor increased the risk of non-adherence by 47 percent. Those with more than two risk factors had a 64 percent greater likelihood of AI non-adherence.

Lead author on the abstract is Dawn L. Hershman, MD, MS, who will present the work at SABCS.

“We recognize that non-adherence to endocrine therapy is multifactorial. Predicting who is at risk will help us target personalized interventions to the right patients,” said Hershman, who is American Cancer Society Professor of Medicine and Epidemiology at Columbia University Irving Medical Center, deputy director of the Herbert Irving Comprehensive Cancer Center, and group co-chair-elect of SWOG Cancer Research Network, a clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

About two-thirds of patients treated for breast cancer have hormone receptor-positive disease, meaning the growth of their tumors is driven by estrogen or progesterone. Women with this type of cancer are often prescribed drugs that reduce hormone production, such as aromatase inhibitors (AIs). 

Clinical trials have shown that taking an AI daily for several years can significantly reduce the chance of the breast cancer returning. But for a variety of reasons, including common side effects such as bone pain and hot flashes, many patients stop taking their AIs early.

The risk model being presented at SABCS was developed using data from the SWOG S1105 clinical trial, a randomized study that enrolled more than 700 post-menopausal women to test whether text message reminders could improve adherence to AI therapy. All patients had been prescribed AI therapy for breast cancer, and they were assessed on the study every three months for continued use of their AI pills. Primary results of the trial, which Hershman led, were published in the Journal of Clinical Oncology in 2020.

To develop the predictive model, the researchers analyzed a set of demographic and financial measures collected when patients joined the S1105 trial. They found four of these measures had statistically significant associations with increased non-adherence to AI therapy: younger age, less education, lower out-of-pocket costs, and living in urban areas. In their data, race and ethnicity were not associated with non-adherence.

“These findings provide further evidence that an individual’s social and economic background can contribute vital information in predicting the course of their treatment,” said senior author Joseph Unger, PhD, associate professor at the Fred Hutchinson Cancer Center and a biostatistician and health services researcher with the SWOG Cancer Research Network. 

“This recognition is important for establishing early on which patients are at much greater risk of non-adherence to long-term AI therapy, which could allow more effective targeting of interventions.”

The authors conclude that such interventions, in addition to steps to relieve symptoms from side effects, should focus on structural barriers in patients at highest risk.
 

Study S1105 was funded by the NIH/NCI through grant UG1CA189974 and in part by the Conquer Cancer Foundation and the Breast Cancer Research Foundation and was conducted through NCI Community Oncology Research Program (NCORP).

In addition to Drs. Hershman and Unger, co-authors include Anna Moseley, MS, SWOG Statistics and Data Management Center and Fred Hutchinson Cancer Center; Kathryn B. Arnold, MS, SWOG Statistics and Data Management Center; Julie R. Gralow, MD, American Society of Clinical Oncology; Alfred I. Neugut, MD, PhD, Herbert Irving Comprehensive Cancer Center, Columbia University ; Scott D. Ramsey, MD, PhD, Fred Hutchinson Cancer Center; and N. Lynn Henry, MD, PhD, University of Michigan Rogel Cancer Center.

SWOG Cancer Research Network is part of the National Cancer Institute's National Clinical Trials Network and the NCI Community Oncology Research Program and is part of the oldest and largest publicly funded cancer research network in the nation. SWOG has 20,000 members in 45 states and nine other countries who design and conduct clinical trials to improve the lives of people with cancer. SWOG trials have led to the approval of 14 cancer drugs, changed more than 100 standards of cancer care, and saved more than 3 million years of human life. Learn more at swog.org, and follow us on Twitter (X) at @SWOG.
 

Reference:

PS04-08: “Sociodemographic Risk Factors and Prediction of Aromatase Inhibitor Non-Adherence in Women with Breast Cancer Enrolled in SWOG S1105,” Hershman, DL, et al. 2023 San Antonio Breast Cancer Symposium.

END


[Attachments] See images for this press release:
Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk 2 Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk 3

ELSE PRESS RELEASES FROM THIS DATE:

Newly developed floating trash interceptor cleans up the river

Newly developed floating trash interceptor cleans up the river
2023-12-06
To reduce marine debris, which causes serious environmental pollution in the sea, researchers at the Korea Institute of Civil Engineering and Building Technology (KICT, President Kim, Byung-suk) have developed a technology for reducing floating debris in rivers. Since the river is the main transportation channels for land-originated marine debris, the research team led by Dr. Sang Hwa Jung launched a living lab project involving local governments, local citizens, and experts. Chungcheongnam-do (also ...

Morressier and senior leaders from academic publishing form Strategic Advisory Board to stimulate positive change in scholarly communications industry

2023-12-06
Berlin, Germany, and Washington, D.C., December 6, 2023 – Morressier, the company transforming scholarly communications, today announced the formation of a new Strategic Advisory Board composed of the most senior leaders from across the scholarly communications community. The Board, which is facilitated and supported by Morressier, will act as a lively, critical, and direct forum, stimulating innovation and collaboration across the industry on crucial issues such as research integrity and publishing workflows. The ...

NIH awards $9 million for Indigenous-led Tribal Data Repository to improve community health in response to COVID-19 pandemic

NIH awards $9 million for Indigenous-led Tribal Data Repository to improve community health in response to COVID-19 pandemic
2023-12-06
In an effort to improve the health of Tribal communities and Indigenous people, the National Institutes of Health (NIH) has awarded $9 million in funding for Native scientists at Arizona State University and elsewhere to create the first Indigenous-led Tribal Data Repository. Since the SARS-CoV-2 worldwide pandemic began, global Indigenous communities have been particularly hard hit, with health disparities including lack of access to health care and undue burden of infections leading to increased hospitalizations and higher death rates. In response, Indigenous researchers and scientists have been working to secure and fund efforts to better understand the impact of COVID-19 and ...

Fascicle gearing dynamics: Unveiling 3D rotation effects in muscle elongation

Fascicle gearing dynamics: Unveiling 3D rotation effects in muscle elongation
2023-12-06
Detailed insights into muscle and tendon movement mechanisms during stretching are essential to improve our overall mobility and flexibility. It is not only important for optimum athletic performance, but also crucial for preventing musculoskeletal injuries. When an individual stretches, 50% to 70% of the elongation is absorbed into the muscle belly, i.e., the fleshy part of the muscle containing most fibers. However, in skeletal muscles with fascicles, the muscle fibers are shorter than the muscle belly and attach to the tendon at an angle. This angle between the fascicles and the tendon changes in response to the length of the muscle belly ...

Greenhouse gases in oceans are altered by climate change impact on microbes – an Incheon National University study

Greenhouse gases in oceans are altered by climate change impact on microbes – an Incheon National University study
2023-12-06
The ocean is a critical life-support system for our planet through its role in global climate regulation. It absorbs most of the carbon emissions and heat trapped in the atmosphere which are a result of human activities. Over the years, this has led to ocean warming (OW), ocean acidification (OA), and ocean deoxygenation (OD). Moreover, increased anthropogenic‑nitrogen-deposition (AND) has largely influenced marine environments. As part of these consequences, the gases nitrous oxide (N2O) and methane (CH4) are largely controlled by 'prokaryotes’ or microbial organisms living in the ocean. While several studies have analyzed ...

New study finds many couples around the world may share high blood pressure

2023-12-06
Research Highlights: A study of married or partnered, middle-aged and older heterosexual couples in the U.S., England, China and India found that in 20% to 47% of the couples, both spouses/partners had high blood pressure. The prevalence of both spouses/partners having high blood pressure was highest in England and the U.S., however, spouses/partners whose spouses/partners had high blood pressure were more likely to also have high blood pressure in China and India. Researchers suggest couple-based interventions to improve high blood pressure diagnosis and management, such as couple-based screening, skills training or joint ...

How drugs can target the thick “scar tissue” of pancreatic cancer

How drugs can target the thick “scar tissue” of pancreatic cancer
2023-12-06
LA JOLLA (December 6, 2023)—Pancreatic cancer is one of the deadliest cancers—only about one in eight patients survives five years after diagnosis. Those dismal statistics are in part due to the thick, nearly impenetrable wall of fibrosis, or scar tissue, that surrounds most pancreatic tumors and makes it hard for drugs to access and destroy the cancer cells. Now, researchers at the Salk Institute have discovered how a class of anti-cancer drugs called HDAC inhibitors can help treat pancreatic cancer by modulating ...

Climate change shown to cause methane to be released from the deep ocean

2023-12-06
New research has shown that fire-ice - frozen methane which is trapped as a solid under our oceans - is vulnerable to melting due to climate change and could be released into the sea. An international team of researchers led by Newcastle University found that as frozen methane and ice melts, methane - a potent greenhouse gas - is released and moves from the deepest parts of the continental slope to the edge of the underwater shelf. They even discovered a pocket which had moved 25 miles (40 kilometres). Publishing in the journal Nature Geoscience, the researchers say this means that much more methane could potentially be vulnerable and released into the atmosphere ...

Influx of water and salts propel immune cells through the body

2023-12-06
Francis Crick Institute press release Under strict embargo: 10:00hrs GMT Wednesday 6 December 2023 Peer reviewed Experimental study Animals Influx of water and salts propel immune cells through the body Researchers at the Francis Crick Institute, working with Imperial College London, King’s College London and University of Cambridge, have shown that an influx of water and ions into immune cells allows them to migrate to where they’re needed in the body.   Our bodies respond to illness by sending out ...

New research reveals a fishing threshold for reef resilience

New research reveals a fishing threshold for reef resilience
2023-12-06
Coral reefs are the most biodiverse systems in the sea and central to the life of many coastal human communities. Half a billion people rely on coral reefs for protection from storms, provision of seafood as well as promotion of tourism and recreation. But climate change is compromising the health of coral reefs globally. Increasing sea temperatures are driving coral bleaching and death. So, the resilience of reefs in the face of climatic challenges is crucial to our collective future, and new research led by Arizona State University has delivered greater understanding of a key aspect of reef health. In a paper published on December 6, 2023, by the London, UK-based journal Proceedings of ...

LAST 30 PRESS RELEASES:

Family care expectations clash with shrinking availability, dementia needs

New device switches terahertz pulses between electric and magnetic skyrmions

Vaping zebrafish suggest E-cigarette exposure disrupts gut microbial networks and neurobehavior

UMass Amherst researchers help uncover hidden genetic drivers of diabetes

Can justice happen on a laptop? Study says yes

Landmark FAU/CSU study: More paid time off keeps US workers from quitting

Traditional and novel virologic markers for functional cure and HBeAg loss with pegylated interferon in chronic hepatitis B

Novel quantum refrigerator benefits from problematic noise

AI tools help decode how TCM formulas work

Rethinking ultrasound gel: a natural solid pad for clearer, more comfortable imaging

Research from IOCB Prague reveals a previously unknown mechanism of genetic transcription

Stimulating the brain with electromagnetic therapy after stroke may help reduce disability

Women with stroke history twice as likely to have another during or soon after pregnancy

Older adults’ driving habits offer window into brain health, cognitive decline

Data analysis finds multiple antiplatelets linked to worse outcomes after a brain bleed

Tear in inner lining of neck artery may not raise stroke risk in first 6 months of diagnosis

New risk assessment tool may help predict dementia after a stroke

Stroke survivors may be less lonely, have better recovery if they can share their feelings

New app to detect social interactions after stroke may help improve treatment, recovery

Protein buildup in brain blood vessels linked with increased 5-year risk of dementia

Immunotherapy before surgery helps shrink tumors in patients with desmoplastic melanoma

Fossilized plankton study gives long-term hope for oxygen depleted oceans

Research clarifies record-late monsoon onset, aiding northern Australian communities

Early signs of Parkinson’s can be identified in the blood

Reducing drug deaths from novel psychoactive substances relies on foreign legislation, but here’s how it can be tackled closer to home

Conveying the concept of blue carbon in Japanese media: A new study provides insights

New Woods Hole Oceanographic Institution study cautions that deep-sea fishing could undermine valuable tuna fisheries

Embedding critical thinking from a young age

Study maps the climate-related evolution of modern kangaroos and wallabies

Researchers develop soft biodegradable implants for long-distance and wide-angle sensing

[Press-News.org] Model uses sociodemographic factors to predict aromatase inhibitor non-adherence risk
Researchers have developed a method to predict early on which patients with breast cancer are most likely to stop taking potentially life-saving aromatase inhibitor drugs